Evox Therapeutics

Preclinical stage company developing an internal and partnered pipeline of exosome-based therapeutics for treating life-threatening rare diseases. Given that delivery is the central issue holding back broader utility of gene therapy, gene editing, and RNA therapeutics, exosomes can enable one or more of these therapeutic classes and result in transformational new treatments for patients.